September 25, 2020

The Niche

Knoepfler lab stem cell blog

Jacob Corn IGI

1 min read

David Jensen reports on the future of CIRM as a “beautiful machine”. CIRM funds brain cancer research in a big way: Funding a clinical trial for deadly cancer is a no brainer. Glioblastoma is a fatal tumor that needs new clinical approaches so this is exciting. One of the goals of my lab is to find new pathways to treat glioblastoma in children. Jacob Corn of IGI has a Wish List for Science on CRISPR science, but also science more generally. The case for possibly retracting a retraction …Read More